Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

JMDC Inc. (6JM.F)

Compare
18.80
+0.30
+(1.62%)
At close: April 17 at 3:29:02 PM GMT+2
Loading Chart for 6JM.F
  • Previous Close 18.50
  • Open 18.70
  • Bid 18.60 x --
  • Ask 19.70 x --
  • Day's Range 18.60 - 18.80
  • 52 Week Range 14.80 - 28.80
  • Volume 5,400
  • Avg. Volume 84
  • Market Cap (intraday) 1.245B
  • Beta (5Y Monthly) 0.53
  • PE Ratio (TTM) 44.76
  • EPS (TTM) 0.42
  • Earnings Date May 7, 2025
  • Forward Dividend & Yield 0.16 (0.70%)
  • Ex-Dividend Date Mar 28, 2024
  • 1y Target Est --

JMDC Inc. provides medical statistics data services in Japan. The company offers medical field big data services; life insurance field big data services; support services for health insurance associations and local government health services; health data platform; and medical institution support services. It serves health insurance unions, pharmaceutical companies, life and non-life insurance companies, research institutions, etc. JMDC Inc. was incorporated in 2002 and is headquartered in Tokyo, Japan. As of October 10, 2023, JMDC Inc. operates as a subsidiary of OMRON Corporation.

www.jmdc.co.jp

1,773

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 6JM.F

View More

Performance Overview: 6JM.F

Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

6JM.F
16.81%
Nikkei 225 (^N225)
12.94%

1-Year Return

6JM.F
5.62%
Nikkei 225 (^N225)
8.80%

3-Year Return

6JM.F
45.67%
Nikkei 225 (^N225)
29.59%

5-Year Return

6JM.F
45.67%
Nikkei 225 (^N225)
74.55%

Compare To: 6JM.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6JM.F

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    1.24B

  • Enterprise Value

    1.35B

  • Trailing P/E

    44.70

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.93

  • Price/Book (mrq)

    2.68

  • Enterprise Value/Revenue

    5.38

  • Enterprise Value/EBITDA

    22.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.03%

  • Return on Assets (ttm)

    3.71%

  • Return on Equity (ttm)

    6.26%

  • Revenue (ttm)

    40.7B

  • Net Income Avi to Common (ttm)

    4.49B

  • Diluted EPS (ttm)

    0.42

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    23.88B

  • Total Debt/Equity (mrq)

    61.26%

  • Levered Free Cash Flow (ttm)

    -127.62M

Research Analysis: 6JM.F

View More

Company Insights: 6JM.F

Research Reports: 6JM.F

View More